Prolacta honors and values breastfeeding mothers and their committment to the health of babies
Clinically proven to improve health outcomes of critically ill preemies
Committed to scientific and clinical research in breast milk
Prolact Product Safety

Executive Management


Scott A. Elster

Chief Executive Officer

Mr. Elster has over 20 years of experience in the biosciences and financial sectors. His experience encompasses planning, finance and strategy development, supply chain, and operations. Most recently, Mr. Elster was director of operations and supply chain at Clinical Micro Sensors (CMS)- a Motorola Company. There, Mr. Elster successfully prepared operations for the company’s first commercial launch, including FDA approval of the GMP manufacturing facility. He led the quality control function, the manufacturing team and operational strategy development. His team was also responsible for materials and inventory management, as well as distribution and warehousing.

For over 13 years at Baxter, Mr. Elster’s management work was focused directly on plasma products worldwide. His roles included manager of strategic planning, business development, finance and strategy for the hyperimmune business unit, and director of global supply chain. Mr. Elster began his career at Deloitte and Touche as a financial statement auditor. He is a board member and past chairman of the board for Monrovia Growers.

Mr. Elster received his Bachelor of Science from California State University, Northridge, and his Master of Business from the Anderson Graduate School of Management at University of California at Los Angeles.

Tami Ciranna, CFO Prolacat  

Tami D. Ciranna

Chief Financial Officer

Ms. Ciranna has over 23 years of experience in finance and accounting. Prior to joining Prolacta, she was the Chief Financial Officer of CommonWealth Partners, a real estate investment firm. Ms. Ciranna oversaw financial planning and analysis, internal and external reporting, finance, accounting, internal controls and guidelines, tax compliance and planning, and compliance with various operating agreements. Ms. Ciranna was responsible for the functional areas of finance, accounting, risk management and administration.

Prior to that, Ms. Ciranna was the lead real estate partner for the Southern California audit practice of Arthur Andersen serving developers, homebuilders and REITS. She spent 13 years working with public, private and international clients, including Fortune 500 clients, in the real estate, products, private foundation and energy industries. While at Andersen, Ms. Ciranna worked on mergers and acquisitions including due diligence for major acquisitions and the related SEC filings and financial reporting. Ms. Ciranna also performed a variety of operational and internal control reviews to ensure compliance with operating guidelines and to improve operations.

Ms. Ciranna graduated from California State University, Los Angeles, where she received a Bachelor of Science, Business Administration, and a minor in Economics, cum laude in 1988, and the University of California, Los Angeles, where she received a Masters in Business Administration in 1998. She is a certified public accountant (inactive status) in the State of California.


Scott Eaker

VP, Quality and Regulatory Affairs

Mr. Eaker is responsible for quality management, regulatory affairs, and laboratory operations for Prolacta Bioscience. He has over 20 years of experience in the bioscience and nutrition sectors. Mr. Eaker began his career in the microbiology laboratory at Baxter Healthcare’s first recombinant Factor VIII manufacturing facility. He supported the start-up of the bulk manufacturing and fill/finish operations, implemented numerous test protocols, led failure investigations, and rapidly became a supervisor of laboratory operations.

Mr. Eaker also held a role serving as the subject matter expert in the areas of microbiology and aseptic processing for Baxter’s Bioscience Division. In this position he was responsible for developing and deploying standardized quality systems across multiple biologic and medical device manufacturing facilities in the U.S. and Europe. Mr. Eaker has also been responsible for quality in the plasma fractionation area and ultimately served as director of quality technical support for the Bioscience Division.

Mr. Eaker received a Bachelor of Science degree in microbiology from the University of California at Davis.

Joe Fournell VP, Operation Systems  

Joseph Fournell

VP, Operation Systems

Mr. Fournell has over a decade of experience in the field of operations and supply chain management in the high-tech and bioscience sectors. Throughout his career, he has held leadership roles in operations, manufacturing execution systems, forecasting, supply planning, process engineering, and logistics.

Most recently, Mr. Fournell served as director of global logistics for Baxter Bioscience. In this capacity, Mr. Fournell managed the transportation, warehousing, and distribution of over $3 billion of product globally. At Baxter Bioscience, he led strategy planning sessions for operations, regulatory, and human resources. In his prior role at Baxter Bioscience, he became the first certified Six Sigma Black Belt in the U.S., working on process improvements in the manufacturing and supply chain arena.

Mr. Fournell received a Bachelor of Science in Industrial Engineering at California Polytechnic State University, San Luis Obispo, with an emphasis on process engineering. He also received a Master of Science degree in Industrial Engineering at California Polytechnic State University, San Luis Obispo, with a focus on factory automation, funded from a grant through NASA-AMES and Raytheon.

Mark Hannon VP, Operations  

Mark Hannon

VP, Operations

Mr. Hannon is responsible for manufacturing operations at Prolacta Bioscience. He has more than 25 years of leadership experience, including 15 years in manufacturing and quality management in the biotechnology, medical, pharmaceutical and food industries. Prior to joining Prolacta, Mr. Hannon led the Hershey company’s second-largest manufacturing operation in the US region.

Mr. Hannon’s career in biotechnology started with Baxter Healthcare, where he held leadership roles in manufacturing, planning and purchasing operations associated with cGMP plasma fractionation, bulk suspension and formulation, sterile bulk preparation, aseptic filling, lyophilization, pasteurization and packaging of plasma derived products. His other roles at Baxter included quality director for a medical device operation, as well as director of manufacturing and plant manager at one of the largest contract manufacturing sites of sterile products (syringes, vials and cartridges) in North America.

Mr. Hannon is a graduate of the United States Military Academy at West Point. He served as a US Army Airborne Ranger Infantry Officer in roles ranging from platoon leader to company commander.

Alan Kofsky, VP of Sales & Marketing, Prolacta  

Alan Kofsky

VP, Sales & Marketing

Mr. Kofsky began his 22 year career working for Mead Johnson’s Infant Nutritional Division. He has held senior sales and marketing positions at both start-up and turnaround companies, as well as at companies in rapid growth circumstances. As vice-president of sales at Whatman, Inc., Mr. Kofsky led three business units, Bioscience, OEM and Distributor Sales, and was instrumental in reviving the struggling microarray business.

Prior to Whatman, Mr. Kofsky spent 13 years at Baxter Healthcare where he held senior sales and marketing positions in the BioScience Division. He led the successful global launch of Gammagard S/D which is a biologic that is used to treat numerous immune disorders. He also directed the launch of Tisseel VH, a product used in the operating room for hemostasis, sealing, and gluing. Additionally, Mr. Kofsky served in a vital leadership role for the successful development of Baxter’s BioSurgery Division which sells and markets a variety of biologics for the hospital operating room.

Mr. Kofsky received his Master of Business Administration from Adelphi University in New York and received his undergraduate degree from the State University of New York at Stony Brook.


Martin L. Lee, Ph.D.

VP, Clinical Research and Development

Dr. Lee is responsible for all research and development activities at Prolacta Bioscience as well as the regulatory compliance function.

He is also Adjunct Professor in the School of Public Health at UCLA and Adjunct Professor of Internal Medicine, Charles R. Drew University of Science and Medicine. Dr. Lee is the author or co-author of over 200 scientific papers. He is a fellow of the Royal Statistical Society and member of the American Statistical Association, the Society for Clinical Trials, the Biometrics Society, and the international Society of Thrombosis and Hemostasis.

Dr. Lee received a Bachelor of Arts (1974) degree in mathematics (summa cum laude), Master of Science, (1975) and, Ph.D. (1979) degree in biostatistics from the University of California, Los Angeles. He has worked for more than 25 years in the pharmaceutical and biotech industries as head of clinical and regulatory functions for these organizations.


Susan Neumann

VP, Milk Procurement

Ms. Neumann is responsible for milk collections and milk bank marketing and operations. She has over 18 years of experience in the healthcare industry in marketing, project management and contract relationship management. Susan began her Prolacta career in 2010 on a consultant basis, and she now manages all aspects of Prolacta’s milk collection efforts. Prior to coming to Prolacta, Susan was co-owner of a franchised home improvement company, where she was responsible for direct to consumer marketing, accounts payable/receivable, employee payroll, and many other office manager functions. Susan’s most recent corporate experience was as Director of Global Marketing at Baxter Bioscience, where she was responsible for strategic marketing for the immunoglobulin and antibody therapy area. Other experience at Baxter included corporate development supporting the biosurgical product line and hyperimmune product line and management of the relationship with the American Red Cross. Susan also worked at the Bushnell Division of Bauch & Lomb in marketing and at Cetus Corporation, a biotechnology company, as a laboratory associate.

Susan received her Bachelor of Science degree in Physiology at the University of California, Davis in 1984, and she received a Master in Business Administration at the University of Southern California in 1988.


David J Rechtman, M.D.

VP, Medical Affairs

Dr. Rechtman received his M.D. from State University of New York - Downstate Medical Center College of Medicine. Following a residency in internal medicine and a fellowship in infectious diseases he served on the faculty of SUNY-Health Science Center at Brooklyn while helping to establish and lead the multi-disciplinary AIDS care team at the affiliated Kings County Hospital.

Upon deciding to pursue a career in industry, Dr. Rechtman was employed at Baxter Healthcare Corporation’s Hyland Division where he was responsible for product safety for the entire product line and medical affairs for immunological and infectious disease products. While at Hyland, he was instrumental in popularizing a highly effective therapy for a serious complication of bone marrow transplantation, as well as helping to achieve new indications for existing products. Subsequently, Dr. Rechtman spent several years as Medical Director for Ribi Immunochem Research Inc. where he was the Medical Officer for the first phase III trial of a commercial therapeutic cancer vaccine, which was targeted against malignant melanoma. That product was subsequently successfully licensed in Canada. He also directed the team developing a product for the prevention of sepsis in high- risk patients.

For the better part of a decade, Dr. Rechtman provided consulting services to various pharmaceutical and biotech companies. These activities subsequently developed into a successful contract research organization that designed and ran clinical trials in the U.S. and abroad. Dr. Rechtman has been an invited speaker at professional gatherings in the U.S. and Europe, has published original research and written chapters for several textbooks, and has given guest lectures to undergraduate and graduate university students in the areas of infectious and immunological diseases and therapies and their development.

Yang Yu, CIO at Prolacta  

Yang Yu

Chief Information Officer (CIO)

Mr. Yu is responsible for overseeing all Information Technology (IT) initiatives and systems for Prolacta Bioscience. He joined the company in 2016 after a 15-year tenure at IBM, where he led major IT projects in the US, China, Taiwan, Hong Kong, India and Malaysia.

At IBM, Mr. Yu was most recently the CIO Enterprise Transformation Leader for the Greater China Group. He gained a wide range of experience and expertise at IBM including ERP system implementation, software development, system support, infrastructure, supply chain processes, and development of global large-scale projects. His proven leadership skills and technical knowledge are tremendous assets supporting Prolacta’s continued growth, success and ability to meet our customers’ needs.

Mr. Yu holds a Bachelor of Science degree in Management Information Systems/Business Administration from University of California Riverside and an MBA from The Hong Kong University of Science and Technology.

Victoria Niklas, MD, Chief Medical and Scientific Officer at Prolacta  

Victoria Niklas, MD

Chief Medical and Scientific Officer

Victoria Niklas, MD is passionate in uncovering the therapeutic potentials in human milk and transforming the knowledge into meaningful solutions in healthcare. She leads the Research & Development team to develop the next generation products from human milk.

Dr. Niklas has nearly three decades of experience as a clinical investigator and neonatologist, integrating basic and translational science into diseases afflicting newborns. She comes to Prolacta after serving as a professor in the Department of Pediatrics at the David Geffen School of Medicine at UCLA, and as director of the Neonatal Intensive Care Unit and Newborn Services at Olive View-UCLA Medical Center.

Victoria earned her medical degree from Harvard Medical School and a master’s degree in Biochemistry and Molecular Biology from Harvard University. She completed her residency in pediatrics at Children’s Hospital Los Angeles and a fellowship in perinatal and neonatal medicine at UCLA.

Follow Us!